Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients

Journal of Human Genetics

Volumn 49, Issue 1, 2004, Pages 40-45

  Uwai, Yuichi ^a   Masuda, Satohiro ^a   Goto, Maki ^a   Motohashi, Hideyuki ^a   Saito, Hideyuki ^a   Okuda, Masahiro ^a   Nakamura, Eijirou ^b   Ito, Noriyuki ^b   Ogawa, Osamu ^b   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Kidney; MDR1; Renal cell carcinoma; SNP

Indexed keywords

MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE EXPRESSION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY CORTEX; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MDR 1 GENE; NEPHRECTOMY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CARCINOMA, RENAL CELL; DNA PRIMERS; FEMALE; FLUORESCENCE; GENES, MDR; HUMANS; JAPAN; KIDNEY CORTEX; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER;

EID: 10744229154     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-003-0105-4     Document Type: Article

References (24)

1. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361-398
2. Chow WH, Devesa SS, Warren JL, Fraumeni, JF Jr (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628-1631
3. Dhote R, Pellicer-Coeuret M, Thiounn N, Debre B, Vidal-Trecan G (2000) Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int 86:20-27
4. Fojo AT, Shen DW, Mickley LA, Pastan I, Gottesman MM (1987) Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene. J Clin Oncol 5:1922-1927
5. Gerloff T, Schaefer M, Johne A, Oselin K, Meisel C, Cascorbi I, Roots I (2002) MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males. Br J Clin Pharmacol 54:610-616
6. Goto M, Masuda S, Saito H, Uemoto S, Kikuchi T, Tanaka K, Inui K (2002) C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation. Pharmacogenetics 12:451-457
7. Hartmann JT, Bokemeyer C (1999) Chemotherapy for renal cell carcinoma. Anticancer Res 19:1541-1544
8. Hashida T, Masuda S, Uemoto S, Saito H, Tanaka K, Inui K (2001) Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. Clin Pharmacol Ther 69:308-316
9. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci 97:3473-3478
10. Kakehi Y, Kanamaru H, Yoshida O, Ohkubo H, Nakanishi S, Gottesman MM, Pastan I (1988) Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance. J Urol 139:862-865
11. Kim WJ, Kakehi Y, Kinoshita H, Arao S, Fukumoto M, Yashida O (1996) Expression patterns of multidrug-resistance (MDR1), multidrug resistance-associated protein (MRP), glutathione-S-transferase-π (GST-π and DNA topoisomerase II (TOPO II) genes in renal cell carcinomas and normal kidney. J Urol 156:506-511
12. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, Taylor A, Xie HG, McKinsey J, Zhou S, Lan LB, Schuetz JD, Schuetz EG, Wilkinson GR (2001) Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 70:189-199
13. Kurata Y, Ieiri I, Kimura M, Morita T, Irie S, Urae A, Ohdo S, Ohtani H, Sawada Y, Higuchi S, Otsubo K (2002) Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Clin Pharmacol Ther 72:209-219
14. Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa O, Inui K (2002) Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 13:866-874
15. Nakamura E, Megumi Y, Kobayashi T, Kamoto T, Ishitoya S, Terachi T, Tachibana M, Matsushiro H, Habuchi T, Kakehi Y, Ogawa O (2002) Genetic polymorphisms of the interleukin-4 receptor α gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population. Clin Cancer Res 8:2620-2625
16. Rodin SM, Johnson BF (1988) Pharmacokinetic interactions with digoxin. Clin Pharmacokinet 15:227-244
17. Schaeffeler E, Eichelbaum M, Brinkmann U, Penger A, Asante-Poku S, Zanger UM, Schwab M (2001) Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet 358:383-384
18. Schuetz EG, Furuya KN, Schuetz JD (1995) Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 275:1011-1018
19. C3435T polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 13:1847-1854
20. Synold TW, Dussault I, Forman BM (2001) The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7:584-590
21. Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R (2002) Single nucleotide polymorphisms of estrogen receptor α in human renal cell carcinoma. Biochem Biophys Res Commun 296:1200-1206
22. 1). J Pharmacol Exp Ther 263:840-845
23. Volm M, Kastel M, Mattern J, Efferth T (1993) Expression of resistance factors (P-glycoprotein, glutathione S-transferase-π, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas. Cancer 71:3981-3987
24. Wakasugi H, Yano I, Ito T, Hashida T, Futami T, Nohara R, Sasayama S, Inui K (1998) Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein. Clin Pharmacol Ther 64:123-128